Company created to nurture individuality in luxury jewellery brands.
WB Creative Jewellery Group Ltd has announced the creation of Advalorem, a new company within the Weston Beamor group formed to provide link between up-and-coming boutique brands and British retailers.
Advalorem will work with the specific intention of nurturing individuality, originality and creativity in fine jewellery and design.
The new company will find and support carefully selected boutique brands and designer-jewellers, from both the UK and overseas and will introduce them to selected British retailers seeking exquisitely-made, luxury products and leading design.
Advalorem is already in the process of launching with its first brand, Vendorafa, a dynamic Italian family firm, dedicated to the pursuit of excellence in both design and manufacture.
The company has a passion for perfection aims to epitomise the heritage, craftsmanship and inimitable “Made in Italy” style through its gold jewellery, traits that are seeing a resurgence as consumers seek out quality and style.
Advalorem will initially be offering ten suites of Vendorafa jewellery, comprising matching necklaces and/or pendants, bracelets, rings and earrings.
A selection of individual bangles, bracelets and brooches are also available. All the jewellery is hand-made in richly-coloured 18ct yellow gold, hand-hammered to create Vendorafa’s celebrated signature texture. Many of the designs have pave diamond accents and all are finished to perfection.
“Advalorem gives WB Creative Jewellery Group the chance to broaden its portfolio and to offer a luxury product which is as beautifully made as it is luxurious. Our market research shows us that Vendorafa’s jewels will appeal to style-conscious women of all ages, and we are confident of a warm reception from leading retailers and their customers countrywide,” said Andrew Morton, managing director of Advalorem.
The task of selling and marketing Vendorafa goes to Ben Williams. Ben will run the new company, under the overall leadership of Group MD, Andrew Morton.